Nat Rev Drug Discov

Computational drug repurposing: approaches, evaluation of in silico resources and case studies.

Tanoli Z, Fernández-Torras A, Özcan UO, ..., Carreras-Puigvert J, Aittokallio T

Nat Rev Drug Discov 24 (7) 521-542 [2025-07-00; online 2025-03-18]

Artificial intelligence for natural product drug discovery.

Mullowney MW, Duncan KR, Elsayed SS, ..., Robinson SL, Medema MH

Nat Rev Drug Discov 22 (11) 895-916 [2023-11-00; online 2023-09-11]

DDLS Fellow Laura Carroll

ENABLE: an engine for European antibacterial drug discovery and development.

Olliver M, Griestop L, Hughes D, ..., Vingsbo Lundberg C, Karlén A

Nat Rev Drug Discov 20 (6) 407-408 [2021-06-00; online 2021-05-06]

Trends in GPCR drug discovery: new agents, targets and indications.

Hauser AS, Attwood MM, Rask-Andersen M, Schiöth HB, Gloriam DE

Nat Rev Drug Discov 16 (12) 829-842 [2017-12-00; online 2017-10-27]

Screening out irrelevant cell-based models of disease.

Horvath P, Aulner N, Bickle M, ..., von Schantz C, Carragher NO

Nat Rev Drug Discov 15 (11) 751-769 [2016-11-00; online 2016-09-12]

Biophysics in drug discovery: impact, challenges and opportunities.

Renaud JP, Chung CW, Danielson UH, ..., Hubbard RE, Nar H

Nat Rev Drug Discov 15 (10) 679-698 [2016-10-00; online 2016-08-12]